Long-term survival and late relapse in 2-year survivors of autologous haematopoietic cell transplantation for Hodgkin and non-Hodgkin lymphoma

British Journal of Haematology

Volumn 147, Issue 1, 2009, Pages 129-139

  Majhail, Navneet S ^a,b   Bajorunaite, Ruta ^c   Lazarus, Hillard M ^d   Wang, Zhiwei ^c,e   Klein, John P ^c   Zhang, Mei Jie ^c   Rizzo, J Douglas ^c,e  

^a CENTER FOR INTERNATIONAL BLOOD AND MARROW TRANSPLANT RESEARCH   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

^d CASE WESTERN RESERVE UNIVERSITY   (United States)

^e CENTER FOR INTERNATIONAL BLOOD AND MARROW TRANSPLANT RESEARCH   (United States)

Author keywords

Autologous haematopoietic cell transplantation; Hodgkin lymphoma; Non Hodgkin lymphoma; Overall survival

Indexed keywords

ADULT; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BURKITT LYMPHOMA; CANCER MORTALITY; CANCER SURVIVAL; CANCER SURVIVOR; CANCER THERAPY; CAUSE OF DEATH; FEMALE; FOLLICULAR LYMPHOMA; FOLLOW UP; GRAFT RECIPIENT; GRAFT SURVIVAL; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; LARGE CELL LYMPHOMA; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; LONG TERM CARE; LYMPHOBLASTOMA; MAJOR CLINICAL STUDY; MALE; MANTLE CELL LYMPHOMA; NONHODGKIN LYMPHOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; SURVIVAL TIME; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; CHILD; EPIDEMIOLOGIC METHODS; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HODGKIN DISEASE; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; RECURRENCE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 70349207133     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2009.07798.x     Document Type: Article

References (35)

1. Andersen, P.K. Vaeth, M. (1989) Simple parametric and nonparametric models for excess and relative mortality. Biometrics, 45, 523 535.
2. Andersen, N.S., Pedersen, L., Elonen, E., Johnson, A., Kolstad, A., Franssila, K., Langholm, R., Ralfkiaer, E., Akerman, M., Eriksson, M., Kuittinen, O. Geisler, C.H. (2003) Primary treatment with autologous stem cell transplantation in mantle cell lymphoma: outcome related to remission pretransplant. European Journal of Haematology, 71, 73 80.
3. Bhatia, S., Robison, L.L., Francisco, L., Carter, A., Liu, Y., Grant, M., Baker, K.S., Fung, H., Gurney, J.G., McGlave, P.B., Nademanee, A., Ramsay, N.K., Stein, A., Weisdorf, D.J. Forman, S.J. (2005) Late mortality in survivors of autologous hematopoietic-cell transplantation: report from the Bone Marrow Transplant Survivor Study. Blood, 105, 4215 4222.
4. Bolwell, B., Kalaycio, M., Sobecks, R., Andresen, S., McBee, M., Kuczkowski, L., Rybicki, L. Pohlman, B. (2002) Autologous hematopoietic cell transplantation non-Hodgkin's lymphoma: 100 month follow-up. Bone Marrow Transplantation, 29, 673 679.
5. Clark, T.G., Altman, D.G. De Stavola, B.L. (2002) Quantification of the completeness of follow-up. Lancet, 359, 1309 1310.
6. Cox, D.R. (1972) Regression models and life tables. Journal of the Royal Statistical Society, 34, 187 202.
7. Dreyling, M., Lenz, G., Hoster, E., Van Hoof, A., Gisselbrecht, C., Schmits, R., Metzner, B., Truemper, L., Reiser, M., Steinhauer, H., Boiron, J.M., Boogaerts, M.A., Aldaoud, A., Silingardi, V., Kluin-Nelemans, H.C., Hasford, J., Parwaresch, R., Unterhalt, M. Hiddemann, W. (2005) Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression-free survival in mantle-cell lymphoma: results of a prospective randomized trial of the European MCL Network. Blood, 105, 2677 2684.
8. Freedman, A.S., Neuberg, D., Gribben, J.G., Mauch, P., Soiffer, R.J., Fisher, D.C., Anderson, K.C., Andersen, N., Schlossman, R., Kroon, M., Ritz, J., Aster, J. Nadler, L.M. (1998) High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle-cell lymphoma: no evidence for long-term remission. Journal of Clinical Oncology, 16, 13 18.
9. Freedman, A.S., Neuberg, D., Mauch, P., Soiffer, R.J., Anderson, K.C., Fisher, D.C., Schlossman, R., Alyea, E.P., Takvorian, T., Jallow, H., Kuhlman, C., Ritz, J., Nadler, L.M. Gribben, J.G. (1999) Long-term follow-up of autologous bone marrow transplantation in patients with relapsed follicular lymphoma. Blood, 94, 3325 3333. (Pubitemid 29536125)
10. Geisler, C.H., Kolstad, A., Laurell, A., Andersen, N.S., Pedersen, L.B., Jerkeman, M., Eriksson, M., Nordstrom, M., Kimby, E., Boesen, A.M., Kuittinen, O., Lauritzsen, G.F., Nilsson-Ehle, H., Ralfkiaer, E., Akerman, M., Ehinger, M., Sundstrom, C., Langholm, R., Delabie, J., Karjalainen-Lindsberg, M.L., Brown, P. Elonen, E. (2008) Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo-purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group. Blood, 112, 2687 2693.
11. Gopal, A.K., Rajendran, J.G., Petersdorf, S.H., Maloney, D.G., Eary, J.F., Wood, B.L., Gooley, T.A., Bush, S.A., Durack, L.D., Martin, P.J., Matthews, D.C., Appelbaum, F.R., Bernstein, I.D. Press, O.W. (2002) High-dose chemo-radioimmunotherapy with autologous stem cell support for relapsed mantle cell lymphoma. Blood, 99, 3158 3162.
12. Gopal, A.K., Gooley, T.A., Maloney, D.G., Petersdorf, S.H., Eary, J.F., Rajendran, J.G., Bush, S.A., Durack, L.D., Golden, J., Martin, P.J., Matthews, D.C., Appelbaum, F.R., Bernstein, I.D. Press, O.W. (2003) High-dose radioimmunotherapy versus conventional high-dose therapy and autologous hematopoietic stem cell transplantation for relapsed follicular non-Hodgkin lymphoma: a multivariable cohort analysis. Blood, 102, 2351 2357.
13. Gorin, N.C., Coiffier, B., Hayat, M., Fouillard, L., Kuentz, M., Flesch, M., Colombat, P., Boivin, P., Slavin, S. Philip, T. (1992) Recombinant human granulocyte-macrophage colony-stimulating factor after high-dose chemotherapy and autologous bone marrow transplantation with unpurged and purged marrow in non-Hodgkin's lymphoma: a double-blind placebo-controlled trial. Blood, 80, 1149 1157.
14. Gyan, E., Foussard, C., Bertrand, P., Michenet, P., Le Gouill, S., Berthou, C., Maisonneuve, H., Delwail, V., Gressin, R., Quittet, P., Vilque, J.P., Desablens, B., Jaubert, J., Ramee, J.F., Arakelyan, N., Thyss, A., Molucon-Chabrot, C., Delepine, R., Milpied, N., Colombat, P. Deconinck, E. (2009) High-dose therapy followed by autologous purged stem cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by the GOELAMS with final results after a median follow-up of 9 years. Blood, 113, 995 1001.
15. Haioun, C., Lepage, E., Gisselbrecht, C., Bastion, Y., Coiffier, B., Brice, P., Bosly, A., Dupriez, B., Nouvel, C., Tilly, H., Lederlin, P., Biron, P., Briere, J., Gaulard, P. Reyes, F. (1997) Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: updated results of the prospective study LNH87-2. Groupe d'Etude des Lymphomes de l'Adulte. Journal of Clinical Oncology, 15, 1131 1137.
16. Huang, B., Law, M.W. Khong, P.L. (2009) Whole-body PET/CT scanning: estimation of radiation dose and cancer risk. Radiology, 251, 166 174.
17. Khouri, I.F., Romaguera, J., Kantarjian, H., Palmer, J.L., Pugh, W.C., Korbling, M., Hagemeister, F., Samuels, B., Rodriguez, A., Giralt, S., Younes, A., Przepiorka, D., Claxton, D., Cabanillas, F. Champlin, R. (1998) Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: an active regimen for aggressive mantle-cell lymphoma. Journal of Clinical Oncology, 16, 3803 3809.
18. Klein, J. Moeschberger, M. 2003) Survival Analysis: Techniques of Censored and Truncated Data. Springer-Verlag, New York.
19. Lazarus, H.M., Rowlings, P.A., Zhang, M.J., Vose, J.M., Armitage, J.O., Bierman, P.J., Gajewski, J.L., Gale, R.P., Keating, A., Klein, J.P., Miller, C.B., Phillips, G.L., Reece, D.E., Sobocinski, K.A., van Besien, K. Horowitz, M.M. (1999) Autotransplants for Hodgkin's disease in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry. Journal of Clinical Oncology, 17, 534 545.
20. Lazarus, H.M., Loberiza, F.R., Jr., Zhang, M.J., Armitage, J.O., Ballen, K.K., Bashey, A., Bolwell, B.J., Burns, L.J., Freytes, C.O., Gale, R.P., Gibson, J., Herzig, R.H., LeMaistre, C.F., Marks, D., Mason, J., Miller, A.M., Milone, G.A., Pavlovsky, S., Reece, D.E., Rizzo, J.D., van Besien, K., Vose, J.M. Horowitz, M.M. (2001) Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR). Bone Marrow Transplantation, 27, 387 396.
21. Linch, D.C., Winfield, D., Goldstone, A.H., Moir, D., Hancock, B., McMillan, A., Chopra, R., Milligan, D. Hudson, G.V. (1993) Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial. Lancet, 341, 1051 1054.
22. Majhail, N.S., Weisdorf, D.J., Defor, T.E., Miller, J.S., McGlave, P.B., Slungaard, A., Arora, M., Ramsay, N.K., Orchard, P.J., MacMillan, M.L. Burns, L.J. (2006) Long-term results of autologous stem cell transplantation for primary refractory or relapsed Hodgkin's lymphoma. Biology of Blood and Marrow Transplantation, 12, 1065 1072.
23. Majhail, N.S., Ness, K.K., Burns, L.J., Sun, C.L., Carter, A., Francisco, L., Forman, S.J., Bhatia, S. Baker, K.S. (2007) Late effects in survivors of Hodgkin and non-Hodgkin lymphoma treated with autologous hematopoietic cell transplantation: a report from the bone marrow transplant survivor study. Biology of Blood and Marrow Transplantation, 13, 1153 1159. (Pubitemid 47413009)
24. Ng, A.K. Travis, L.B. (2008) Second primary cancers: an overview. Hematology/Oncology Clinics of North America, 22, 271 289, vii.
25. Philip, T., Guglielmi, C., Hagenbeek, A., Somers, R., Van der Lelie, H., Bron, D., Sonneveld, P., Gisselbrecht, C., Cahn, J.Y., Harousseau, J.L., Coiffier B, Biron.P., Mandelli, F. Chauvin, F. (1995) Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. New England Journal of Medicine, 333, 1540 1545.
26. Rabinowe, S.N., Neuberg, D., Bierman, P.J., Vose, J.M., Nemunaitis, J., Singer, J.W., Freedman, A.S., Mauch, P., Demetri, G., Onetto, N. et al (1993) Long-term follow-up of a phase III study of recombinant human granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid malignancies. Blood, 81, 1903 1908. (Pubitemid 23101607)
27. Ramlou-Hansen, H. (1983) Smoothing counting process intensities by means of kernel functions. Annals of Statistics, 11, 453 466.
28. Sebban, C., Brice, P., Delarue, R., Haioun, C., Souleau, B., Mounier, N., Brousse, N., Feugier, P., Tilly, H., Solal-Celigny, P. Coiffier, B. (2008) Impact of rituximab and/or high-dose therapy with autotransplant at time of relapse in patients with follicular lymphoma: a GELA study. Journal of Clinical Oncology, 26, 3614 3620.
29. Sodickson, A., Baeyens, P.F., Andriole, K.P., Prevedello, L.M., Nawfel, R.D., Hanson, R. Khorasani, R. (2009) Recurrent CT, cumulative radiation exposure, and associated radiation-induced cancer risks from CT of adults. Radiology, 251, 175 184.
30. Sweetenham, J.W., Carella, A.M., Taghipour, G., Cunningham, D., Marcus, R., Della Volpe, A., Linch, D.C., Schmitz, N. Goldstone, A.H. (1999) High-dose therapy and autologous stem-cell transplantation for adult patients with Hodgkin's disease who do not enter remission after induction chemotherapy: results in 175 patients reported to the European Group for Blood and Marrow Transplantation. Lymphoma Working Party. Journal of Clinical Oncology, 17, 3101 3109.
31. Van Besien, K., Tabocoff, J., Rodriguez, M., Andersson, B., Mehra, R., Przepiorka, D., Dimopoulos, M., Giralt, S., Suki, S., Khouri, I., Spitzer, G., Jagannath, S., Dicke, K., Le Maistre, C.F., Deisseroth, A., Cabannillas, F., Champlin, R.E. (1995) High-dose chemotherapy with BEAC regimen and autologous bone marrow transplantation for intermediate grade and immunoblastic lymphoma: durable complete remissions, but a high rate of regimen-related toxicity. Bone Marrow Transplantation, 15, 549 555.
32. Vandenberghe, E., Ruiz de Elvira, C., Loberiza, F.R., Conde, E., Lopez-Guillermo, A., Gisselbrecht, C., Guilhot, F., Vose, J.M., van Biesen, K., Rizzo, J.D., Weisenburger, D.D., Isaacson, P., Horowitz, M.M., Goldstone, A.H., Lazarus, H.M. Schmitz, N. (2003) Outcome of autologous transplantation for mantle cell lymphoma: a study by the European Blood and Bone Marrow Transplant and Autologous Blood and Marrow Transplant Registries. British Journal of Haematology, 120, 793 800.
33. Vose, J.M., Zhang, M.J., Rowlings, P.A., Lazarus, H.M., Bolwell, B.J., Freytes, C.O., Pavlovsky, S., Keating, A., Yanes, B., van Besien, K., Armitage, J.O. Horowitz, M.M. (2001) Autologous transplantation for diffuse aggressive non-Hodgkin's lymphoma in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry. Journal of Clinical Oncology, 19, 406 413.
34. Vose, J.M., Rizzo, D.J., Tao-Wu, J., Armitage, J.O., Bashey, A., Burns, L.J., Christiansen, N.P., Freytes, C.O., Gale, R.P., Gibson, J., Giralt, S.A., Herzig, R.H., Lemaistre, C.F., McCarthy, P.L., Jr., Nimer, S.D., Petersen, F.B., Schenkein, D.P., Wiernik, P.H., Wiley, J.M., Loberiza, F.R., Lazarus, H.M., van Biesen, K. Horowitz, M.M. (2004) Autologous transplantation for diffuse aggressive non-Hodgkin lymphoma in first relapse or second remission. Biology of Blood and Marrow Transplantation, 10, 116 127.
35. Wadehra, N., Farag, S., Bolwell, B., Elder, P., Penza, S., Kalaycio, M., Avalos, B., Pohlman, B., Marcucci, G., Sobecks, R., Lin, T., Andresen, S. Copelan, E. (2006) Long-term outcome of Hodgkin disease patients following high-dose busulfan, etoposide, cyclophosphamide, and autologous stem cell transplantation. Biology of Blood and Marrow Transplantation, 12, 1343 1349.